BioVie Awarded Up To $13.1M In Funding From US Department of Defense To Evaluate Bezisterim (NE3107) For Long COVID, The Study Is Expected To Start In Early 2025
BioVie獲得了美國國防部高達1310萬美元的資助,用於評估Bezisterim(NE3107)對長期COVID的評估,該研究預計將於2025年初開始
BioVie Awarded Up To $13.1M In Funding From US Department of Defense To Evaluate Bezisterim (NE3107) For Long COVID, The Study Is Expected To Start In Early 2025
BioVie獲得了美國國防部高達1310萬美元的資助,用於評估Bezisterim(NE3107)對長期COVID的評估,該研究預計將於2025年初開始
使用瀏覽器的分享功能,分享給你的好友吧